Decision Maker's Toolkit
Essential Documentation for Your Evaluation.
Technical specifications, compliance frameworks, and ROI projections for executives, CSOs, and IT leaders evaluating sovereign AI infrastructure for pharmaceutical R&D.
Core Documents
The Decision Maker's Toolkit
The Sovereign AI Whitepaper
"Maintaining GxP Compliance in the Age of Generative Intelligence"
How pharmaceutical companies can leverage AI while meeting FDA 21 CFR Part 11, EU AI Act High-Risk Category, and GxP validation requirements. Essential reading for CSOs and regulatory heads.
ROI Analysis
"Quantifying the Cost of the 6-Month Regulatory Filing Delay"
Financial impact analysis of regulatory delays and how AI-accelerated documentation reduces time-to-submission. Includes projection models, payback period calculations, and opportunity cost frameworks.
Integration Guide
"Deploying Air-Gapped LLMs within Existing R&D Tech Stacks"
Technical blueprint for IT and data teams. Covers model orchestration, local vector storage, NVIDIA H100/B200 hardware requirements, ELN integration, and security architecture.
Access Resources
Download the Complete Toolkit
Enter your details to receive immediate access to all three core documents, plus executive summaries and technical appendices.
Additional Materials
Supplementary Evaluation Resources
VIDEO
Platform Demo
Kuberex agents in action across regulatory, synthesis, and clinical workflows.
CASE STUDY
Implementation Stories
How biopharma organizations deploy sovereign AI infrastructure.
FAQ
Common Questions
Deployment timelines, security protocols, and integration requirements.
TECHNICAL
API Documentation
Technical specs for integration and development teams.
Get Started
Ready to Bring SINA to Your Lab?
Start a 30-day pilot with your own data. See how SINA transforms your evidence synthesis and regulatory drafting workflows on the Kuberex platform.